©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Feb 26, 2020; 12(2): 100-109
Published online Feb 26, 2020. doi: 10.4252/wjsc.v12.i2.100
Published online Feb 26, 2020. doi: 10.4252/wjsc.v12.i2.100
Mesenchymal stem cells from different sources and their derived exosomes: A pre-clinical perspective
María Álvarez-Viejo, Unidad de Terapia Celular y Medicina Regenerativa, Servicio de Hematología y Hemoterapia, Hospital Universitario Central de Asturias, Oviedo 33011, Spain
María Álvarez-Viejo, Plataforma de Terapias Avanzadas, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo 33011, Spain
Author contributions: Álvarez-Viejo M wrote the paper.
Conflict-of-interest statement: Author declare no conflicts of interest related to this article.
Corresponding author: María Álvarez-Viejo, PhD, Associate Professor, Unidad de Terapia Celular y Medicina Regenerativa, Servicio de Hematología y Hemoterapia, Hospital Universitario Central de Asturias, Oviedo 33011, Spain. maria.alvarezv@sespa.es
Received: August 29, 2019
Peer-review started: August 29, 2019
First decision: November 12, 2019
Revised: December 18, 2019
Accepted: January 14, 2020
Article in press: January 14, 2020
Published online: February 26, 2020
Processing time: 181 Days and 23.3 Hours
Peer-review started: August 29, 2019
First decision: November 12, 2019
Revised: December 18, 2019
Accepted: January 14, 2020
Article in press: January 14, 2020
Published online: February 26, 2020
Processing time: 181 Days and 23.3 Hours
Core Tip
Core tip: This article reviews the use of exosomes derived from mesenchymal stem cells to treat various disease states and discusses their possible clinical applications.